Results 351 to 360 of about 3,851,688 (392)
Some of the next articles are maybe not open access.

Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial

The Lancet, 2007
B. Escudier   +14 more
semanticscholar   +1 more source

Poly(ADP-Ribose) polymerase (PARP) inhibitors: Exploiting a synthetic lethal strategy in the clinic

Ca-A Cancer Journal for Clinicians, 2011
Timothy A Yap, Johann Sebastian de Bono
exaly  

Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension

The Lancet, 1997
J. Staessen   +17 more
semanticscholar   +1 more source

Autophagy during viral infection — a double-edged sword

Nature Reviews Microbiology, 2018
Younho Choi, Jae U Jung
exaly  

Directional DBS increases side‐effect thresholds—A prospective, double‐blind trial

Movement Disorders, 2017
T. Dembek   +9 more
semanticscholar   +1 more source

Non-homologous DNA end joining and alternative pathways to double-strand break repair

Nature Reviews Molecular Cell Biology, 2017
Noritaka Adachi, Michael R Lieber
exaly  

Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial

The Lancet, 2012
I. Pavord   +7 more
semanticscholar   +1 more source

DNA double-strand break repair-pathway choice in somatic mammalian cells

Nature Reviews Molecular Cell Biology, 2019
Ralph Scully   +2 more
exaly  

Home - About - Disclaimer - Privacy